Print

AVEO Oncology (Formerly known as AVEO Pharmaceuticals, Inc.) (AVEO) to Host Conference Call and Webcast to Review Phase 3 TIVO-1 Data Presented at American Society of Clinical Oncology  
5/30/2012 10:45:27 AM

CAMBRIDGE, Mass.--(BUSINESS WIRE)--AVEO Oncology (Nasdaq: AVEO) today announced that the AVEO management team will host a conference call on Monday, June 4, 2012 at 7:30 a.m. (CT) to review the Phase 3 TIVO-1 data that will be presented at the 2012 Annual Meeting of the American Society of Clinical Oncology (ASCO). The call can be accessed by dialing 1-800-215-2410 (domestic) or 1-617-597-5410 (international) five minutes prior to the start of the call and providing the passcode 59157252. A replay of the call will be available approximately two hours after the completion of the call and can be accessed by dialing 1-888-286-8010 (domestic) or 1-617-801-6888 (international), providing the passcode 77088629.
//-->